Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.21.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash $ 1,305,652 $ 3,523
Prepaid Expenses 363,848
Total current assets 1,669,500 3,523
Deferred offering costs 30,000
Cash and Investments held in Trust Account 300,010,072
Total Assets 301,679,572 33,523
Current liabilities:    
Accrued offering costs and expenses 201,055
Promissory note - related party 9,284
Total current liabilities 201,055 9,284
Deferred underwriting fee 10,500,000
Warrant liability 9,240,000
Total liabilities 19,941,055 9,284
Commitments
Common Stock subject to possible redemption, 27,673,851 and no shares at redemption value at June 30, 2021 and December 31, 2020, respectively 276,738,510
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Class A common stock, $0.0001 par value; 100,000,000 shares authorized; 3,126,149 and 0 shares issued and outstanding (excluding 27,673,851 and no shares subject to possible redemption) at June 30, 2021 and December 31, 2020, respectively 313
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,500,000 and 7,618,750 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively [1] 750 762
Additional paid-in capital 6,553,366 24,238
Retained earnings (accumulated deficit) (1,554,422) (761)
Total stockholders’ equity 5,000,007 24,239
Total Liabilities and Stockholders’ Equity $ 301,679,572 $ 33,523
[1] Shares at December 31, 2020 included up to 993,750 founder Class B shares subject to forfeiture by the Sponsor if over-allotment option was not exercised in full or in part by the underwriters (see Note 5).